Skip to main content
. 2024 Jan 6;47(3):261–270. doi: 10.1007/s40264-023-01389-y
We validated a novel method for the assessment of the quality of pregnancy pharmacovigilance data.
This approach shows less inter-rater variability compared with a quality assessment by experts.